Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MATSUDA, H.
Right arrow Articles by SARUTA, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MATSUDA, H.
Right arrow Articles by SARUTA, T.
J Am Soc Nephrol 10:2272-2282, 1999
© 1999 American Society of Nephrology

Zonal Heterogeneity in Action of Angiotensin-Converting Enzyme Inhibitor on Renal Microcirculation

Role of Intrarenal Bradykinin

HIROTO MATSUDA*, KOICHI HAYASHI*, KOKI ARAKAWA*, MAREO NAITOH*, EIJI KUBOTA*, MASANORI HONDA*, AKIRA MATSUMOTO*, HIROMICHI SUZUKI{dagger}, TOKUNORI YAMAMOTO{ddagger}, FUMIHIKO KAJIYA{ddagger} and TAKAO SARUTA*

* Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
{dagger} Department of Nephrology, Saitama Medical School, Saitama, Japan
{ddagger} Department of Medical Engineering and Systems Cardiology, Kawasaki Medical School, Okayama, Japan.

Correspondence to Dr. Takao Saruta, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. Phone: +81 3 3353 1211, extension 2312; Fax: +81 3 3359 2745; E-mail: saruta{at}mc.med.keio.ac.jp

Abstract. The present study examined the role of intrarenal bradykinin in angiotensin-converting enzyme inhibitor (ACEI)-induced dilation of renal afferent (AFF) and efferent arterioles (EFF) in vivo, and further evaluated whether ACEI-stimulated bradykinin activity differed in superficial (SP) and juxtamedullary nephrons (JM). Arterioles of canine kidneys were visualized with an intravital charge-coupled device camera microscope. E4177 (an angiotensin receptor antagonist, 30 µg/kg) dilated AFF and EFF in SP (15 ± 3% and 19 ± 5%) and JM (15 ± 3% and 18 ± 4%). Subsequently, cilazaprilat (30 µg/kg) caused further dilation of both AFF (29 ± 4%) and EFF (36 ± 4%) in JM, whereas in SP it dilated only EFF (29 ± 3%). Similarly, in the presence of E4177, cilazaprilat caused further increases in sodium excretion. This cilazaprilat-induced vasodilation and natriuresis was abolished by a bradykinin antagonist (N{alpha}-adamantaneacetyl-D-Arg-[Hyp3,Thi5,8,D-Phe7]-bradykinin). In parallel with these results, cilazaprilat increased renal bradykinin content, more greatly in the medulla than in the cortex (5.7 ± 0.4 versus 4.6 ± 0.1 ng/g). Similarly, cilazaprilat elicited greater bradykinin-dependent increases of nitrite/nitrate in the medulla. In conclusion, zonal heterogeneity in renal bradykinin/nitric oxide levels and segmental differences in reactivity to bradykinin contribute to the diverse responsiveness of renal AFF and EFF to ACEI. ACEI-enhanced kinin action would participate in the amelioration of glomerular hemodynamics and renal sodium excretion by ACEI.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta
Ca2+ Channel Subtypes and Pharmacology in the Kidney
Circ. Res., February 16, 2007; 100(3): 342 - 353.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force Members, J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: The Task Force on ACE-inhibitors of the European Society of Cardiology
Eur. Heart J., August 2, 2004; 25(16): 1454 - 1470.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig
Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Imig
ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement
Hypertension, March 1, 2004; 43(3): 533 - 535.
[Full Text] [PDF]


Home page
HypertensionHome page
H. Matsuda, K. Hayashi, S. Wakino, E. Kubota, M. Honda, H. Tokuyama, I. Takamatsu, S. Tatematsu, and T. Saruta
Role of Endothelium-Derived Hyperpolarizing Factor in ACE Inhibitor-Induced Renal Vasodilation in Vivo
Hypertension, March 1, 2004; 43(3): 603 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Tokuyama, K. Hayashi, H. Matsuda, E. Kubota, M. Honda, K. Okubo, I. Takamatsu, S. Tatematsu, Y. Ozawa, S. Wakino, et al.
Differential Regulation of Elevated Renal Angiotensin II in Chronic Renal Ischemia
Hypertension, July 1, 2002; 40(1): 34 - 40.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Yamamoto, Y. Tomura, H. Tanaka, and F. Kajiya
In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats
Am J Physiol Renal Physiol, September 1, 2001; 281(3): F571 - F577.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M C. Lansang and N. K Hollenberg
ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 119 - 124.
[PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Tokuyama, K. Hayashi, H. Matsuda, E. Kubota, M. Honda, K. Okubo, Y. Ozawa, and T. Saruta
Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia
Am J Physiol Renal Physiol, May 1, 2002; 282(5): F859 - F865.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP